Clinical trial
Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in…
NCT00046501 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00046501 |
|---|---|
| Title | Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents |
| Official title | Morning LANTUS v. Intermediate-acting Insulin 2x/Day as Basal Insulin in a Multiple Daily Inj. w/ Humalog in Adolescents w/ Type 1 Diabetes Mellitus: an Active-controlled, Open, Randomized, Gender-stratified, Two-arm, Parallel-group Study |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Lantus (insulin glargine [rDNA origin] injection), Humulin N, Humulin L, Lispro |
| Enrollment | 250 |
| Start date | Nov 1, 2002 |
| Primary completion | Feb 1, 2005 |
| First posted | Oct 2, 2002 |
| Last update posted | Jan 11, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: